Home › Funds › Marble Bar Asset Management LLP › RNA
Marble Bar Asset Management LLP position in RNA
ATRIUM THERAPEUTICS INC · Health Care
Marble Bar Asset Management LLP reported holding 103,849 shares of RNA (ATRIUM THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.4M, representing 0.97% of its reported portfolio and ranking #18 among its reported holdings. Marble Bar Asset Management LLP has disclosed RNA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Marble Bar Asset Management LLP's RNA position evolved
Marble Bar Asset Management LLP first disclosed a stake in RNA in Q1 2026 at 147,000 shares (US$2.0M). Across 2 filings, Marble Bar Asset Management LLP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 103,849 shares valued at US$1.4M — a reduction of -43,151 shares quarter over quarter.. Notable position changes include a 29% trim in Q2 2026 (shares fell 38% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 147.00K | $1.97M | New |
| Q2 2026 | 103.85K | $1.40M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RNA and 13F data
RNA (ATRIUM THERAPEUTICS INC) is a Health Care company. 116 other funds we track also report a position in RNA — the largest reported positions include Sessa Capital IM, L.P. (US$20.2M), CRCM LP (US$8.6M), TIG Advisors, LLC (US$7.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RNA
- Sessa Capital IM, L.P. 1.50M sh · $20.18M · Q2 2026
- CRCM LP 641.54K sh · $8.63M · Q2 2026
- TIG Advisors, LLC 561.53K sh · $7.55M · Q2 2026
- Arbiter Partners Capital Management LLC 261.29K sh · $3.51M · Q2 2026
- Slotnik Capital, LLC 237.64K sh · $3.20M · Q2 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 150.03K sh · $2.02M · Q2 2026
- Bracebridge Capital, LLC 139.24K sh · $1.87M · Q2 2026
- Yakira Capital Management, Inc. 133.05K sh · $1.79M · Q2 2026
- Creek Drive Management Group LLC 127.60K sh · $1.72M · Q2 2026
- Athos Capital Ltd 107.97K sh · $1.45M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 43.76K sh · $588.54K · Q2 2026
- Trium Capital LLP 58.38K sh · $483.40K · Q3 2026
More on Marble Bar Asset Management LLP
FAQ
How long has Marble Bar Asset Management LLP held RNA?
Marble Bar Asset Management LLP has disclosed RNA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Marble Bar Asset Management LLP's current position in RNA?
As of Q2 2026, Marble Bar Asset Management LLP holds 103.85K shares of RNA (ATRIUM THERAPEUTICS INC), valued at $1.40M, representing 0.97% of its reported portfolio and ranking #18.
Has Marble Bar Asset Management LLP been buying or selling RNA?
In the latest 13F filing (Q2 2026), Marble Bar Asset Management LLP reduced its position in RNA.
Which other funds hold RNA?
Other major institutional holders of RNA include Sessa Capital IM, L.P., CRCM LP, TIG Advisors, LLC, among 116 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.